Jyong Biotech Ltd. (MENS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$2.60M2024: -$3.62M2025: -$3.04M-$3.04M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$3.04M+16.1%
2024-$3.62M-39.3%
2023-$2.60M